23 May 2013
 

2006 Vol.24, N°6 - Suppl.43 - Table of contents

Title: Remission in rheumatic diseases

Audio summaries of each article may be downloaded directly in MP3 format, or downloaded from AppleiTunes music store.

CME Credit available through Vanderbilt University.

The Journal thanks Abbott, Amgen Inc., Bristol-Myers Squibb, Centocor Inc., Hoffman LaRoche, Novartis Pharmaceuticals Corporation, UCB, Wyeth Pharmaceuticals for support of this Supplement.

pictures and PubMed Link of our Authors pictures and PubMed Link of our Authors.

Webmaster for the Supplement: Andrea Stancati, M.D. Italy

Subscribe to our PodCast for free on iTunes Music Store (need Apple iTunes installed) or download the audio files in .mp3 format.

Purchase all articles

Page 1

PageArticle - [Author(s)]PDFAbs.CMEAudioMedia
Introduction
CER2865
2006,24,6,Suppl.43
Pg. 0001-0006
Complexities in defining remission in rheumatic diseases
T. Pincus, A. Kavanaugh, D. Aletaha, J. Smolen › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
Remission in rheumatoid arthritis
CER2866
2006,24,6,Suppl.43
Pg. 0007-0013
What should be our treatment goal in rheumatoid arthritis today?
J.S. Smolen, D. Aletaha › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
 
CER2867
2006,24,6,Suppl.43
Pg. 0014-0021
ACR remission criteria and response criteria
V. K. Ranganath, D. Khanna, H. E. Paulus › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
 
CER2868
2006,24,6,Suppl.43
Pg. 0022-0028
Definitions of remission for rheumatoid arthritis and review of selected clinical cohorts and randomised clinical trials for the rate of remission
H. Mäkinen, P. Hannonen, T. Sokka › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
 
CER2869
2006,24,6,Suppl.43
Pg. 0029-0032
DAS remission cut points
J. Fransen, P.L.C.M. van Riel › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
 
CER2870
2006,24,6,Suppl.43
Pg. 0033-0036
Can remission be maintained with or without further drug therapy in rheumatoid arthritis?
B. Saleem, S. Nizam, P. Emery › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
 
CER2871
2006,24,6,Suppl.43
Pg. 0037-0040
Remission and radiographic progression in rheumatoid arthritis
A.E. Voskuyl, B.A.C. Dijkmans › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
 
CER2872
2006,24,6,Suppl.43
Pg. 0041-0044
Is remission in rheumatoid arthritis associated with radiographic healing?
R. Rau › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
Alternatives to strict remission in RA
CER2873
2006,24,6,Suppl.43
Pg. 0045-0051
Remission of rheumatoid arthritis: should we care about definitions?
D. Aletaha, J.S. Smolen › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
 
CER2874
2006,24,6,Suppl.43
Pg. 0052-0059
Low disease activity state in rheumatoid arthritis: concepts and derivation of minimal disease activity
G. Wells, M. Boers, P. Tugwell › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
 
CER2875
2006,24,6,Suppl.43
Pg. 0060-0073
A proposed approach to recognise “near-remission” quantitatively without formal joint counts or laboratory tests: a patient self-report questionnaire routine assessment of patient index data (RAPID) score as a guide to a “continuous quality improvement” s
T. Pincus, Y. Yazici, M. Bergman, C. Swearingen, T. Harrington › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
Clinical trials and other studies in which low disease activity or remission has been used as an endpoint
CER2876
2006,24,6,Suppl.43
Pg. 0074-0076
Remission as the treatment goal – the FIN-RACo trial
T. Sokka, H. Mäkinen, K. Puolakka, T. Möttönen, P. Hannonen › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
 
CER2877
2006,24,6,Suppl.43
Pg. 0077-0082
Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study
C.F. Allaart, Y.P.M. Goekoop-Ruiterman, J.K. de Vries-Bouwstra, F.C. Breedveld, B.A.C. Dijkmans, FARR study group › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
Remission in rheumatic diseases other than RA
CER2878
2006,24,6,Suppl.43
Pg. 0083-0087
Defining remission in psoriatic arthritis
A. Kavanaugh, J. Fransen › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
 
CER2879
2006,24,6,Suppl.43
Pg. 0088-0092
Remission in ankylosing spondylitis
J. Zochling, J. Braun › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
 
CER2880
2006,24,6,Suppl.43
Pg. 0093-0098
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis
C. Mukhtyar, B. Hellmich, D. Jayne, O. Flossmann, R. Luqmani › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
 
CER2881
2006,24,6,Suppl.43
Pg. 0099-0104
Assessing remission in systemic lupus erythematosus
M. Mosca, S. Bombardieri › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
 
CER2882
2006,24,6,Suppl.43
Pg. 0105-0110
Remission in juvenile idiopathic arthritis
A. Ravelli, A. Martini › Free to View
Rheumatology ArticleRheumatology AbstractCMERheumatology Article - Audio 
A journal-based CME Activity
CER2883
2006,24,6,Suppl.43
Pg. 0111-0120
Clinical and Experimental Rheumatology: Remission in Rheumatic Diseases
› Free to View
Rheumatology ArticleRheumatology Abstract   

Page 1

This journal-based Continuing Medical Education (CME) activity has bee jointly sponsored by Vanderbilt University School of Medicine and Abbott Immunology, Amgen Inc., .Bristol-Myers Squibb, Centocor Inc., Genentech, Novartis Pharmaceuticals Corporation, Pfizer Inc., Wyeth Pharmaceuticals.

This issue is valid for obtaining a maximum of 20 category 1 credits toward the AMA Physician's Recognition Award. Each article has been certified for 0.5 category 1 credit. Each physician should claim only those credits that he/she actually spent in the activity.

To receive the CME credit, for US physicians, please go to page S208-S221

Top of the Page

  • Help Center
  • Utilities

Quality

Web sites for on line Journals
© Clinical and Experimental Rheumatology (Journal with On line Submission) ISSN n° 1593-098X
- VAT IT-00783170509